Press Releases

The following are official statements issued by UsAgainstAlzheimer’s in response to major national policy actions, industry events, breaking news, or organizational achievements. Please see the UsAgainstAlzheimer’s press kit page for additional information. For media requests, please contact Jon Summers at [email protected].

  • June 17, 2022

    UsAgainstAlzheimer’s Statement on Crenezumab Trial Results

    Washington, DC (June 16, 2022) — Today, UsAgainstAlzheimer’s Chair and co-founder George...

    Read more
  • June 09, 2022

    UsAgainstAlzheimer’s Center for Brain Health Equity Launches Brain Health Equity Nurse Fellowship

    Washington, DC (June 9, 2022)— Today, UsAgainstAlzheimer’s Center for Brain Health...

    Read more
  • May 26, 2022

    UsAgainstAlzheimer’s Launches Brain Health Academy

    Washington, DC (May 26, 2022)— Today UsAgainstAlzheimer’s announced the launch of...

    Read more
  • April 14, 2022

    Alzheimer’s Patient Advocates File FOIA Seeking Answers on Discriminatory Medicare Coverage Decision

    Today, UsAgainstAlzheimer’s announced their latest effort to demand answers from the Centers...

    Read more
  • April 07, 2022

    It’s Official: CMS Denies Medicare Coverage to Alzheimer’s Patients

    “Little difference, a lot of uncertainty” in Coverage Determination

     

    Read more
  • April 01, 2022

    Barragán Leads Colleagues in Call to CMS to Revise Their Non-Coverage Decision for An Entire Class of Alzheimer's Treatments

    Yesterday, Congresswoman Nanette Diaz Barragán led 40 of her colleagues in the...

    Read more
  • March 30, 2022

    Biden Administration and Congress Take a Major Step to Accelerate Research to Treat and Cure Serious Illnesses

    Modeled after DARPA, ARPA-H will incentivize innovative approaches to address some of...

    Read more
  • March 23, 2022

    CMS Proposal Would Leave Millions of Patients Without Access to FDA-approved Alzheimer’s Treatments in CMS Clinical Trials

    Under a proposed rule from the Centers for Medicare and Medicaid Services...

    Read more
  • March 21, 2022

    Warner & Markey Lead Colleagues in a Call to Fairly Evaluate Alzheimer's Treatments

     Sens. Mark R. Warner (D-VA) and Ed Markey (D-MA), Co-Chairs of theCongressional...

    Read more

Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s

The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer's. This report found that deep social inequities exist in countries highly impacted by Alzheimer's among Latinos and Blacks.

Read Report